Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CGIX

Cancer Genetics (CGIX) Stock Price, News & Analysis

Cancer Genetics logo

About Cancer Genetics Stock (NASDAQ:CGIX)

Advanced Chart

Key Stats

Today's Range
$0.18
$0.20
50-Day Range
$0.15
$4.61
52-Week Range
$2.11
$17.50
Volume
19,116 shs
Average Volume
2.44 million shs
Market Capitalization
$792,490.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vyant Bio, Inc. is a biotechnology company, which engages in drug discovery for complex neurodevelopmental and neurodegenerative disorders. The firm's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. Its programs are focused on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome, CDKL5 Deficiency Disorders, and familial Parkinson's Disease. The company was founded on April 8, 1999 and is headquartered in Cherry Hill, NJ.

Receive CGIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cancer Genetics and its competitors with MarketBeat's FREE daily newsletter.

CGIX Stock News Headlines

Man who predicted $100K Bitcoin sees a huge run coming for another coin …
Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.
See More Headlines

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:CGIX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$6.33 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$792,490.00
Optionable
Not Optionable
Beta
2.72
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:CGIX) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners